Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinico-Pathological Factors and AR-LBD Mutations in Early and Late Castration-Resistant Prostate Cancer.

Cancer management and research·2024
Same author

Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (M<sup>pro</sup>) Autocleavage Enzyme Critical for COVID-19 Pathogenesis.

Journal of dietary supplements·2021
Same author

Epigenetic Regulation of Gut Microbial Dysbiosis.

Indian journal of microbiology·2021
Same author

Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-α and NF-kB pathway in diabetes-induced nephropathy.

The Journal of pharmacy and pharmacology·2018
Same author

Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.

BMC complementary and alternative medicine·2018
Same author

Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2017

Related Experiment Video

Updated: May 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Diabetic nephropathy: causes and managements.

Yamini B Tripathi1, Durgavati Yadav

  • 1Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. yaminiok@yahoo.com

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|December 12, 2012
PubMed
Summary

Diabetic nephropathy (DN) management requires multi-targeted drugs due to complex pathways. Herbal preparations offer a promising adjuvant therapy due to their natural compounds targeting multiple mechanisms.

Related Experiment Videos

Last Updated: May 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

  • Pharmacology
  • Nephrology
  • Herbal Medicine

Background:

  • Diabetic nephropathy (DN) is a common complication of uncontrolled diabetes, affecting kidney function.
  • DN pathogenesis involves multiple molecular pathways including oxidative stress and inflammation.
  • Current management often requires combination therapies.

Purpose of the Study:

  • To review the pathogenesis of diabetic nephropathy.
  • To explore multi-targeted drug approaches for DN management.
  • To highlight recent patents and bio-products in DN drug development.

Main Methods:

  • Literature review of DN pathogenesis.
  • Analysis of multi-targeted drug strategies.
  • Survey of recent patents and pipeline bio-products for DN.

Main Results:

  • DN involves complex molecular pathways necessitating multi-targeted interventions.
  • Herbal preparations are increasingly favored as adjuvant therapies due to their natural compounds.
  • Several novel bio-products and patented compounds are under development for DN.

Conclusions:

  • Effective diabetic nephropathy management requires addressing its multifaceted pathogenesis.
  • Herbal medicines show potential as adjuvant therapies for DN.
  • Ongoing research and development are yielding new therapeutic options for DN.